EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation

Yuanchao Shi, Zhenzhong Pan, Jingwei Duan, Zexing Wang, Yiliang Fang, Bo Tang, Quanlin Guan

Biomolecules and Biomedicine · 2025

DOI: 10.17305/bb.2025.11663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Yuanchao Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Academy of Lanzhou University, Lanzhou University, Lanzhou, China; Department of General Surgery and Gastrointestinal Oncology Sur…. Hauptthemen laut MEDLINE: Sialyltransferases, Colorectal Neoplasms, Antigens, CD, Antigens, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ST6 β-galactoside α2,6-sialyltransferase 1 (ST6GAL1), a crucial enzyme for tumor-associated sialic acid modification, has been reported to positively correlate with colorectal cancer (CRC) tumorigenesis; however, the underlying mechanism remains unclear. To elucidate the protumor mechanisms of ST6GAL1, we performed transcriptomic and N-glycoproteomic analyses and in vitro assays. We found that ST6GAL1 was significantly upregulated in tumor samples than in matched normal samples by analyzing fresh clinical samples from public databases (mean mRNA expression level: tumor vs. normal samples = 0.002712:0.000966, P < 0.05, n = 22). The in vitro results revealed that ST6GAL1 overexpression promoted CRC cell proliferation, migration, and chemoresistance, which were significantly blocked by its knockdown. Transcriptomic data showed that many genes related to the four modules (proliferation/cell cycle, migration, motility, and epithelial–mesenchymal transition (EMT) were upregulated after ST6GAL1 overexpression but downregulated after ST6GAL1 knockdown. Furthermore, the N-glycoproteomic data revealed that 25 substrates that were sialylated upon ST6GAL1 overexpression were related to protumor activity. Importantly, we found that knockdown of lectin galactoside-binding soluble 3-binding protein (LGALS3BP), a newly identified secreted substrate of ST6GAL1, significantly blocked the proliferation, invasion, and chemoresistance of CRC cells induced by ST6GAL1 overexpression. Treatment with sialidases (neuraminidases, NAs) also blocked the protumor activity of ST6GAL1. Thus, ST6GAL1-induced increased sialylation of substrates, such as LGALS3BP and upregulation of protumor genes promote CRC tumorigenesis and chemoresistance, which provides important perspectives and new targets for the treatment of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SialyltransferasesColorectal NeoplasmsAntigens, CDAntigens, NeoplasmHumansCell ProliferationCell MovementDisease ProgressionCell Line, TumorGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionProteomicsTranscriptomeMultiomicsbeta-D-Galactoside alpha 2-6-SialyltransferaseBiomarkers, TumorExtracellular Matrix Proteins

Substanzen

SialyltransferasesAntigens, CDAntigens, Neoplasmbeta-D-Galactoside alpha 2-6-SialyltransferaseBiomarkers, TumorST6GAL1 protein, humanLGALS3BP protein, humanExtracellular Matrix Proteins

Autor:innen und Institutionen

  • The First Clinical Academy of Lanzhou University, Lanzhou University, Lanzhou, China; Department of General Surgery and Gastrointestinal Oncology Surgery, Lanzhou University First Hospital, Lanzhou, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Emergency department, Peking University Third Hospital, Beijing, China.
  • School of Medicine, Chongqing University, Chongqing, China.
  • Department of Neurology, Army Medical University Xinqiao Hospital, Chongqing, China.
  • Department of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Third Military Medical University Southwest Hospital, Chongqing, China.

Zitieren

APA

Shi, Y., Pan, Z., Duan, J., Wang, Z., Fang, Y., Tang, B., & Guan, Q. (2025). Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2025.11663

Vancouver

Shi Y, Pan Z, Duan J, Wang Z, Fang Y, Tang B, et al. Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2025.11663

BibTeX
@article{Shi2025,
  author = {Shi, Yuanchao and Pan, Zhenzhong and Duan, Jingwei and Wang, Zexing and Fang, Yiliang and Tang, Bo and Guan, Quanlin},
  title = {Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  doi = {10.17305/bb.2025.11663}
}
Kostenlos starten →